The Pharmacy Times® Depression Resource Center is a comprehensive resource for clinical news and expert insights on treatments for the different forms of depression and its symptoms.
April 10th 2024
However, psychedelic medicine has a variety of barriers, including historical perception, access challenges, legal obstacles, and ethical questions.
The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia
1.5 Credits / Neurology, Psychiatry
View More
Managing Bipolar Disorder: The Pharmacist’s Role in Delivering Quality Care
1.0 Credits / Psychiatry
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Clinical Overview: Auvelity (Dextromethorphan and Bupropion) for Major Depressive Disorder
November 8th 2022With many different classes of medications used in the treatment of major depressive disorder, pharmacists can have a significant impact on patients' lives, from counseling on medications to assisting with finding the right medication.
Read More
Trends in Behavioral and Mental Health Treatment Since the Start of the Pandemic
October 10th 2022New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.
Read More
Research Finds Access to Recreational Marijuana Reduces Demand for Prescription Drugs
April 20th 2022When states legalize marijuana, the volume of prescriptions within the drug classes that align with the medical indications for pain, depression, anxiety, sleep, psychosis, and seizures significantly decline.
Read More